ALKS

Alkermes (ALKS)

Alkermes PLC

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ALKS

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/15	05:30	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:ALKS	Alkermes PLC
2024/05/14	20:00	PR Newswire (US)	Alkermes Highlights Data Presentations Related to its Psychiatry Franchise at Spring 2024 Scientific Conferences	NASDAQ:ALKS	Alkermes PLC
2024/05/14	20:00	PR Newswire (US)	Alkermes Highlights Data Presentations Related to its Psychiatry Franchise at Spring 2024 Scientific Conferences	NASDAQ:ALKS	Alkermes PLC
2024/05/02	20:00	PR Newswire (US)	Alkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk	NASDAQ:ALKS	Alkermes PLC
2024/05/01	20:00	PR Newswire (US)	Alkermes plc Reports First Quarter 2024 Financial Results	NASDAQ:ALKS	Alkermes PLC
2024/04/24	20:00	PR Newswire (US)	Alkermes Announces Initiation of Vibrance-1 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 1	NASDAQ:ALKS	Alkermes PLC
2024/04/18	05:00	PR Newswire (US)	Alkermes to Report First Quarter Financial Results on May 1, 2024	NASDAQ:ALKS	Alkermes PLC
2024/04/18	05:00	PR Newswire (US)	Alkermes to Report First Quarter Financial Results on May 1, 2024	NASDAQ:ALKS	Alkermes PLC
2024/04/09	20:00	PR Newswire (US)	Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia	NASDAQ:ALKS	Alkermes PLC
2024/04/09	20:00	PR Newswire (US)	Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia	NASDAQ:ALKS	Alkermes PLC
2024/04/08	20:00	PR Newswire (US)	Alkermes Presents Analyses From Long-Term Safety Study of LYBALVI® (olanzapine and samidorphan) at 2024 Congress of the Schizophrenia International Research Society	NASDAQ:ALKS	Alkermes PLC
2024/03/07	21:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALKS	Alkermes PLC
2024/03/07	21:00	PR Newswire (US)	Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors	NASDAQ:ALKS	Alkermes PLC
2024/02/28	06:09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/02/28	06:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/02/28	06:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/02/28	06:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/02/28	06:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/02/24	06:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/02/24	06:13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/02/24	06:09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/02/24	06:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/02/24	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/02/24	06:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/02/22	07:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/02/22	07:38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/02/22	07:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/02/22	07:32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/02/22	07:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/02/22	07:27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC